Agency Forms Undergoing Paperwork Reduction Act Review, 76044-76045 [2012-30929]
Download as PDF
<![CDATA[
76044
Federal Register / Vol. 77, No. 247 / Wednesday, December 26, 2012 / Notices
• Which of the services listed were
covered by the plan? Routine vision care
for children, Routine dental care for
children, Mental health care, and
Substance abuse treatment will be
added Routine vision care for adults and
Routine dental care for adults will
replace Routine vision care and Routine
dental care respectively. Chiropractic
care remains unchanged.
• Is this a Grandfathered health plan
as defined by the Affordable Care Act?
Yes/No/Don’t know
Deletions
• How many different pricing
categories or tiers of prescription drug
coverage were there for this plan?
Number of tiers lll or Don’t know
• What was the MAXIMUM amount
this plan would have paid for an
enrollee in ONE YEAR? $lll or No
annual maximum
• An employer can offer a Health
Reimbursement Arrangement (HRA) by
setting up an account to reimburse
employees for medical expenses not
covered by health insurance. Did your
organization offer an HRA associated
with this plan in 2013? HRAs are NOT
Flexible Spending Accounts (FSAs) or
Health Savings Accounts (HSAs). Yes/
No/Don’t Know
The MEPS Definitions form—MEPS–
20(D)—will also be updated with new
definitions for terms used in these new
questions (and the deletion of terms
used only in the deleted questions).
There are no changes to the 2013
MEPS–IC survey estimates of cost and
hour burdens due to these proposed
question changes. The response rate for
the MEPS–IC survey also is not
expected to change due to these
proposed changes.
The MEPS–IC is conducted pursuant
to AHRQ’s statutory authority to
conduct surveys to collect data on the
cost, use and quality of health care,
including the types and costs of private
health insurance. 42 U.S.C. 299b–2(a).
Method of Collection
There are no changes to the current
data collection methods.
Estimated Annual Respondent Burden
There are no changes to the current
burden estimates.
Estimated Annual Costs to the Federal
Government
tkelley on DSK3SPTVN1PROD with
There are no changes to the current
cost estimates.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
VerDate Mar<15>2010
06:31 Dec 22, 2012
Jkt 229001
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: December 13, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–30631 Filed 12–21–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day-13–0612]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Well-Integrated Screening and
Evaluation for Women Across the
Nation (WISEWOMAN) Reporting
System (OMB #0920–0612, exp. 3/31/
2013)—Extension—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Background and Brief Description
The WISEWOMAN program (WellIntegrated Screening and Evaluation for
Women Across the Nation),
administered by the Centers for Disease
Control and Prevention (CDC), was
established to examine ways to improve
the delivery of services for women who
have limited access to health care and
elevated risk factors for cardiovascular
disease (CVD). The program focuses on
reducing CVD risk factors and provides
screening services for select risk factors
such as elevated blood cholesterol,
hypertension and abnormal blood
glucose levels. The program also
provides lifestyle interventions and
medical referrals. On an annual basis,
21 grantees funded through the
WISEWOMAN program have provided
services to approximately 30,000
women who are already participating in
the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP),
also administered by CDC.
CDC seeks a one-year extension of
OMB approval to collect information
about WISEWOMAN grantee activities
in the final year of the five-year
cooperative agreement. There are no
changes to the number of respondents,
the data items reported to CDC, the
estimated burden per response, or the
total estimated annualized burden. All
information will continue to be
collected twice per year.
Information reported to CDC includes
baseline and follow-up data (12 months
post enrollment) for all women served
through the WISEWOMAN program.
These data, called the minimum data
elements (MDE), include data elements
that describe risk factors for the women
served in each program and data
elements that describe the number and
type of intervention sessions attended.
Funded grantees compile the data from
their existing databases and report the
MDE to CDC electronically. The
estimated burden per response for
Screening and Assessment MDE is 16
hours, and the estimated burden per
response for Lifestyle Intervention MDE
is 8 hours.
WISEWOMAN grantees also submit
semi-annual progress reports that
describe programmatic activities, public
education and outreach, professional
education, and the delivery of services.
Progress reports will continue to be
submitted to CDC in hardcopy format.
The estimated burden per response for
each progress report is 16 hours.
The information collection is
designed to support continuous program
monitoring and improvement. CDC uses
the MDE data to assess the effectiveness
of the WISEWOMAN program in
E:\FR\FM\26DEN1.SGM
26DEN1
76045
Federal Register / Vol. 77, No. 247 / Wednesday, December 26, 2012 / Notices
reducing the burden of cardiovascular
disease risk factors among women who
utilize program services. CDC uses the
information submitted through progress
reports to assess each grantee’s progress
toward meeting stated program
objectives. Participation in the
information collection is required under
the terms of the WISEWOMAN
cooperative agreement.
OMB approval is requested for one
year. The total estimated annualized
burden hours are 1,680.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
WISEWOMAN Grantees .................................
Screening and Assessment MDE ..................
Lifestyle Intervention MDE .............................
Progress Report .............................................
Dated: December 18, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012–30929 Filed 12–21–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-13–0573]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
tkelley on DSK3SPTVN1PROD with
The National HIV Surveillance
System (NHSS) (OMB No. 0920–0573,
Expiration 01/31/2013)-RevisionNational Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC). This title is being
changed from the previously approved
title Adult and Pediatric HIV/AIDS
Confidential Case Reports for National
HIV/AIDS Surveillance in 2009.
Background and Brief Description
The purpose of HIV surveillance is to
monitor trends in HIV and describe the
characteristics of infected persons (e.g.,
VerDate Mar<15>2010
06:31 Dec 22, 2012
Jkt 229001
demographics, modes of exposure to
HIV, clinical and laboratory markers of
HIV disease, manifestations of severe
HIV disease, and deaths among persons
with HIV). HIV surveillance data are
widely used at all government levels to
assess the impact of HIV infection on
morbidity and mortality, to allocate
medical care resources and services, and
to guide prevention and disease control
activities.
CDC, in collaboration with health
departments in the 50 states, the District
of Columbia, and U.S. dependent areas,
conduct national surveillance for cases
of HIV infection. National surveillance
includes tracking critical data across the
spectrum of HIV disease from HIV
diagnosis, to AIDS, the end-stage
disease caused by infection with HIV,
and death. In addition, this national
system provides essential data to
estimate HIV incidence and monitor
patterns in viral resistance and HIV–1
subtypes, as well as provide information
on perinatal exposures in the U.S.
The CDC surveillance case definition
has been modified periodically to
accurately monitor disease in adults,
adolescents and children and reflect use
of new testing technologies and changes
in HIV treatment. Information is then
updated in the case report forms and
reporting software as needed. In 2012,
CDC convened an expert consultation to
consider revisions of various aspects of
the case definition including criteria for
reporting a potential case, criteria for
reporting a confirmed case, and case
classification (disease staging system).
Recommendations for revisions in the
case definition were adopted by the
Council of State and Territorial
Epidemiologists in June 2012 and the
final case definition revision is planned
for implementation in 2013 after
publication.
The revisions requested include
modifications to currently collected data
elements and forms to align with
anticipated changes in the case
definitions for HIV surveillance to be
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
21
21
21
Number of
responses
per respondent
2
2
2
Average
burden per
response
(in hr)
16
8
16
published in 2012 and continuation of
HIV surveillance activities funded
under the new funding opportunity
announcement CDC–RFA–PS13–1302
National HIV Surveillance System
(NHSS). These include minor
modifications of testing categories to
accommodate new testing algorithms
and modifications to staging criteria and
non-substantial editorial changes aimed
at improving the format and usability of
the forms such as improved wording of
terms and changes in the format of some
response options. In addition, the
number of data elements from the
former enhanced perinatal surveillance
(EPS) was reduced and the form
modified for continuation in 2013 as
Perinatal HIV Exposure Reporting
(PHER). Surveillance data collection on
variant and atypical strains (formerly
variant, atypical and resistant HIV
surveillance (VARHS)) will be
continued as Molecular HIV
Surveillance (MHS) with a reduced
number of data elements previously
approved under VARHS.
CDC provides funding for 59
jurisdictions to conduct adult and
pediatric HIV case surveillance. Health
department staffs compile information
from laboratories, physicians, hospitals,
clinics and other health care providers
in order to complete the HIV and
pediatric case reports. Updates to case
reports are also entered into enhanced
HIV/AIDS Reporting system (eHARS) by
health departments, as additional
information may be received from
laboratories, vital statistics offices, or
additional providers. Evaluations are
also conducted by health departments
on a subset of case reports (e.g.
including re-abstraction/validation
activities and routine interstate deduplication) in all jurisdictions.
Supplemental surveillance data are
collected in a subset of areas to provide
additional information necessary to
estimate HIV incidence, to better
describe the extent of HIV viral
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 77, Number 247 (Wednesday, December 26, 2012)]
[Notices]
[Pages 76044-76045]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30929]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-13-0612]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-7570 or send an email to
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-5806.
Written comments should be received within 30 days of this notice.
Proposed Project
Well-Integrated Screening and Evaluation for Women Across the
Nation (WISEWOMAN) Reporting System (OMB 0920-0612, exp. 3/31/
2013)--Extension--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
The WISEWOMAN program (Well-Integrated Screening and Evaluation for
Women Across the Nation), administered by the Centers for Disease
Control and Prevention (CDC), was established to examine ways to
improve the delivery of services for women who have limited access to
health care and elevated risk factors for cardiovascular disease (CVD).
The program focuses on reducing CVD risk factors and provides screening
services for select risk factors such as elevated blood cholesterol,
hypertension and abnormal blood glucose levels. The program also
provides lifestyle interventions and medical referrals. On an annual
basis, 21 grantees funded through the WISEWOMAN program have provided
services to approximately 30,000 women who are already participating in
the National Breast and Cervical Cancer Early Detection Program
(NBCCEDP), also administered by CDC.
CDC seeks a one-year extension of OMB approval to collect
information about WISEWOMAN grantee activities in the final year of the
five-year cooperative agreement. There are no changes to the number of
respondents, the data items reported to CDC, the estimated burden per
response, or the total estimated annualized burden. All information
will continue to be collected twice per year.
Information reported to CDC includes baseline and follow-up data
(12 months post enrollment) for all women served through the WISEWOMAN
program. These data, called the minimum data elements (MDE), include
data elements that describe risk factors for the women served in each
program and data elements that describe the number and type of
intervention sessions attended. Funded grantees compile the data from
their existing databases and report the MDE to CDC electronically. The
estimated burden per response for Screening and Assessment MDE is 16
hours, and the estimated burden per response for Lifestyle Intervention
MDE is 8 hours.
WISEWOMAN grantees also submit semi-annual progress reports that
describe programmatic activities, public education and outreach,
professional education, and the delivery of services. Progress reports
will continue to be submitted to CDC in hardcopy format. The estimated
burden per response for each progress report is 16 hours.
The information collection is designed to support continuous
program monitoring and improvement. CDC uses the MDE data to assess the
effectiveness of the WISEWOMAN program in
[[Page 76045]]
reducing the burden of cardiovascular disease risk factors among women
who utilize program services. CDC uses the information submitted
through progress reports to assess each grantee's progress toward
meeting stated program objectives. Participation in the information
collection is required under the terms of the WISEWOMAN cooperative
agreement.
OMB approval is requested for one year. The total estimated
annualized burden hours are 1,680.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hr)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Grantees.................... Screening and Assessment 21 2 16
MDE.
Lifestyle Intervention 21 2 8
MDE.
Progress Report......... 21 2 16
----------------------------------------------------------------------------------------------------------------
Dated: December 18, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-30929 Filed 12-21-12; 8:45 am]
BILLING CODE 4163-18-P
